CoV-GLUE Lineage: AY.91.1
Table of countries and their respective (filtered) sequence count for the lineage 'AY.91.1'.
| Lineage | Country | Count | EarliestEpiWeek | LatestEpiWeek | View Mutations | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 |
| AY.91.1 | All | 246 | 76 | 93 | Mutations | 3 | 4 | 12 | 7 | 1 | 2 | 9 | 14 | 10 | 24 | 46 | 50 | 37 | 11 | 8 | 5 | 2 | 1 |
| AY.91.1 | DENMARK | 123 | 84 | 91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 15 | 36 | 34 | 30 | 4 | 2 | 1 | 0 | 0 | |
| AY.91.1 | NETHERLANDS | 40 | 78 | 92 | 0 | 0 | 7 | 4 | 1 | 2 | 5 | 10 | 1 | 2 | 1 | 3 | 1 | 0 | 1 | 1 | 1 | 0 | |
| AY.91.1 | GERMANY | 29 | 76 | 92 | 1 | 2 | 3 | 2 | 0 | 0 | 2 | 2 | 0 | 5 | 2 | 3 | 4 | 0 | 2 | 0 | 1 | 0 | |
| AY.91.1 | SWITZERLAND | 24 | 86 | 91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 7 | 2 | 5 | 2 | 2 | 0 | 0 | |
| AY.91.1 | TURKEY | 18 | 78 | 93 | 0 | 0 | 1 | 1 | 0 | 0 | 2 | 2 | 6 | 0 | 1 | 0 | 0 | 2 | 1 | 1 | 0 | 1 | |
| AY.91.1 | FRANCE | 3 | 76 | 77 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| AY.91.1 | ITALY | 2 | 85 | 85 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| AY.91.1 | BELGIUM | 2 | 87 | 87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| AY.91.1 | POLAND | 1 | 78 | 78 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| AY.91.1 | CROATIA | 1 | 84 | 84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| AY.91.1 | SLOVENIA | 1 | 87 | 87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| AY.91.1 | NAMIBIA | 1 | 76 | 76 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| AY.91.1 | ISRAEL | 1 | 84 | 84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
 |
 |
CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk
|